Healthcare >> CEO Interviews >> October 26, 2004
MARTIN A. SIMONETTI has served as Chief Financial Officer and Treasurer
of Dendreon Corporation since joining the company in 1999 and Senior
Vice President, Finance since January 2001. Prior to joining Dendreon,
Mr. Simonetti was employed at Amgen Inc., most recently serving as Vice
President, Operations and Finance of Amgen BioPharma and its Director of
Colorado Operations. From 1984 to 1991, Mr. Simonetti worked at
Genentech, Inc., first as a scientist in its Medicinal and Analytical
Chemistry Department and later as a Financial Analyst and Group
Controller. Mr. Simonetti serves on the Board of Directors of
IntegriGen, Inc., based in Novato, California, and he is a member of the
Dean's Executive Advisory Board for the Albers School of Business and
Economics at Seattle University. Mr. Simonetti received an MS in
Nutrition from the University of California, Davis and an MBA from the
University of Santa Clara. Profile
of your products?
Mr. Simonetti: Dendreon Corporation (NASDAQ: DNDN) was formed in 1992.
Our mission is to target cancer
